The epicardial delivery of cardiosphere derived cells or their extracellular vesicles is safe but of limited value in experimental infarction

The epicardial administration of therapeutics via the pericardial sac offers an attractive route, since it is minimally invasive and carries no risks of coronary embolization. The aim of this study was to assess viability, safety and effectiveness of cardiosphere-derived cells (CDCs), their extracel...

Descripción completa

Detalles Bibliográficos
Autores principales: Crisóstomo, Verónica, Baéz-Diaz, Claudia, Blanco-Blázquez, Virginia, Álvarez, Verónica, López-Nieto, Esther, Maestre, Juan, Bayes-Genis, Antoni, Gálvez-Montón, Carolina, Casado, Javier G., Sánchez-Margallo, Francisco M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590017/
https://www.ncbi.nlm.nih.gov/pubmed/34772964
http://dx.doi.org/10.1038/s41598-021-01728-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590017/
https://www.ncbi.nlm.nih.gov/pubmed/34772964
http://dx.doi.org/10.1038/s41598-021-01728-y

Ejemplares similares